BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28132018)

  • 1. Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    Pelosof L; Ahn C; Gao A; Horn L; Madrigales A; Cox J; McGavic D; Minna JD; Gazdar AF; Schiller J
    J Natl Cancer Inst; 2017 Jan; 109(7):. PubMed ID: 28132018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2010 Feb; 5(2):158-68. PubMed ID: 20040896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion and clinical features of never-smokers with non-small cell lung cancer.
    Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
    Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
    Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-small cell lung cancer in never smokers: a clinical entity to be identified.
    Santoro IL; Ramos RP; Franceschini J; Jamnik S; Fernandes AL
    Clinics (Sao Paulo); 2011; 66(11):1873-7. PubMed ID: 22086516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple primary malignancies in patients with non-small cell lung cancer.
    Fujita S; Masago K; Takeshita J; Togashi Y; Hata A; Kaji R; Kokubo M; Katakami N
    Intern Med; 2015; 54(3):325-31. PubMed ID: 25748742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer in never-smokers - what are the differences?
    Dias M; Linhas R; Campainha S; Conde S; Barroso A
    Acta Oncol; 2017 Jul; 56(7):931-935. PubMed ID: 28514931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2009 Sep; 4(9):1083-93. PubMed ID: 19652625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.
    Bhatt VR; Batra R; Silberstein PT; Loberiza FR; Ganti AK
    Med Oncol; 2015 Jan; 32(1):339. PubMed ID: 25429831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.
    Thomas A; Mian I; Tlemsani C; Pongor L; Takahashi N; Maignan K; Snider J; Li G; Frampton G; Ali S; Kim S; Nichols S; Rajapakse V; Guha U; Sharon E; Fujimoto J; Moran CA; Wistuba II; Wei JS; Khan J; Szabo E; Torres AZ; Carson KR
    Chest; 2020 Oct; 158(4):1723-1733. PubMed ID: 32464188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.
    Yano T; Haro A; Shikada Y; Maruyama R; Maehara Y
    Int J Clin Oncol; 2011 Aug; 16(4):287-93. PubMed ID: 21562939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
    Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases.
    Kawaguchi T; Matsumura A; Fukai S; Tamura A; Saito R; Zell JA; Maruyama Y; Ziogas A; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 Jul; 5(7):1001-10. PubMed ID: 20526205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
    Bryant A; Cerfolio RJ
    Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.
    Ng TL; Liu Y; Dimou A; Patil T; Aisner DL; Dong Z; Jiang T; Su C; Wu C; Ren S; Zhou C; Camidge DR
    Cancer; 2019 Apr; 125(7):1038-1049. PubMed ID: 30548240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J; Velcheti V; Gao F; Govindan R
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018.
    Tseng JS; Chiang CJ; Chen KC; Zheng ZR; Yang TY; Lee WC; Hsu KH; Huang YH; Liu TW; Hsia JY; Chang GC
    JAMA Netw Open; 2022 Mar; 5(3):e224830. PubMed ID: 35353165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population.
    Rasco DW; Yan J; Xie Y; Dowell JE; Gerber DE
    J Thorac Oncol; 2010 Oct; 5(10):1529-35. PubMed ID: 20631635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 20. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Soo RA; Kubo A; Ando M; Kawaguchi T; Ahn MJ; Ou SI
    Clin Lung Cancer; 2017 Sep; 18(5):535-542. PubMed ID: 28433570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.